➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
McKinsey
Medtronic
Harvard Business School
AstraZeneca

Last Updated: January 25, 2021

DrugPatentWatch Database Preview

Litigation Details for Meda Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2015)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Meda Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .
Biologic Drugs cited in Meda Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc.
The biologic drug covered by the patents cited in this case is   Start Trial .

Details for Meda Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2015)

Date Filed Document No. Description Snippet Link To Document
2016-11-10 101 Exhibit A ’428 Patent PH U.S. Patent No. 6,759,398 (see, e.g., Col. …00001339. U.S. Patent No. 6,759,398 (see, e.g., Col. … The ’620, 723, and ’428 patents arise from the same patent family and share substantially similar… ’723, and ’428 patents contain many of the same references. For citations to patents, the parties incorporate… MEDA_TEVA_00000733 (Non-Patent U.S. Patent No. 5,889,015 (see, e.g., Col. External link to document
2016-11-13 104 Correction ("CoC") for U.S. Patent No. 9,259,428 ('" 428 patent") into this case. (D.I…inadvertent typographical errors" in the '428 patent. (D.I. 62 at 1) "On May 3, 2016, the PTO issued…requested Certificate of Correction for the '428 patent." (Id.) Plaintiffs explain that thereafter…indefiniteness arguments regarding claim 28 of '_428 patent, arguments that would be affected by introduction…litigating the uncorrected version of the '428 patent. (See D.I. 65 at 5) (discussing litigation that External link to document
2016-12-06 113 of U.S. Patent Nos. 8,163,723; 8,168,620; and 9,259,428. With respect to the '428 patent, the PTO…construe claims 28-30 of the '428 patent, which, in the uncorrected patent, contain a typographical error…addressing construction of claims 28-30 of the '428 patent, within one week of the date of this order. Signed…additional exhibits are documents from the '428 patent's prosecution history, including a listing …in the,context of claims 28-30 of the '428 patent. 3. D~fendant opposes Plaintiffs External link to document
2016-03-18 28 Initial Infringement Contentions for U.S. Patent Nos. 8,163,723, 8,168,620, and 9,259,428 filed by Cipla…2015 28 July 2017 1:15-cv-00785 830 Patent None District Court, D. Delaware External link to document
2015-09-08 4 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,163,723; 8,168,620;. (sar) …2015 28 July 2017 1:15-cv-00785 830 Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Merck
Moodys
Medtronic
Baxter
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.